The allele interaction between apolipoprotein ε2 and ε4 in Taiwanese Alzheimer's disease patients

Acta Psychiatrica Scandinavica

Volumn 111, Issue 1, 2005, Pages 38-43

  Lung, For Wey ^a   Yen, Y C ^a,b   Chou, L J ^c   Hong, C J ^d   Wu, C K ^e  

^a KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b Calo Psychiatric Center   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e Jing Ho Mental Hospital   (Taiwan)

Author keywords

Alzheimer's disease; Apolipoprotein E; Polymorphism

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E4;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TAIWAN;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-CULTURAL COMPARISON; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENES, DOMINANT; GENOTYPE; HUMANS; MALE; RISK; TAIWAN;

EID: 12744281264     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2004.00394.x     Document Type: Article

References (52)

1. MAHLEY RW. Apolipoprotein E: cholesterol transport protein with an expanding role in cell biology. Science 1988;240:622-630.
2. BOYLES JK, ZOELLNER CD, ANDERSON LJ et al. A role for apolipoprotein E, apolipoprotein A-1, and low-density lipoprotein receptors in cholesterol transport during regeneration and remyelination of rat sciatic nerve. J Clin Invest 1989;83:1015-1031.
3. MANN DMA. Alzheimer's disease: progress in pathological and aetiological aspects. Rev Clin Gerontol 1994;4:43-60.
4. WISNIEWSKI T, GOLABEK A, MATSUBARS E, GHISO J, FRANGIONE B. Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Commun 1993;192:359-365.
5. UTERMANN G, HEES M, STEINMETZ A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 1977;269:604-607.
6. BOUTHILLIER D, SING CF, DAVIGNON J. Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings. J Lipid Res 1983;24:1060-1069.
7. ZANNIS VI, BRESLOW JL, UTERMANN G et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 1982;23:911-914.
8. SCHMECHEL DE, SAUNDERS AM, STRITTMATTER W et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993; 90:9649-9653.
9. MAYEUX R, STERN Y, OTTMAN R et al. The apolipoprotein epsilon4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-754.
10. POIRIER J, DAVIGNON J, BOUTHILLIER D, KOGAN S, BERTRAND P, GAUTHIER S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699.
11. SAUNDERS AM, STRITTMATTER WJ, SCHMECHEL D et al. Association of apolipoprotein allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
12. BROUSSEAU T, LEGRAIN S, BERR C, GOURLET V, VIDAL O, AMOUYEL P. Confirmation of the epsilon4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 1994;44:342-344.
13. CHARTIER-HARLIN MC, PARFITT M, LEGRAIN S et al. Apolipoprotein E, epsilon4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994; 3:569-574.
14. PEACOCK ML, FINK JK. ApoE allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology 1994;44: 339-341.
15. TSAI MS, TANGALOS EG, PETERSEN RC et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 1994;54:643-649.
16. YU CE, PAYAMI H, OLSON JM et al. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet 1994;54:631-642.
17. CORDER EH, SAUNDERS AM, RISCH NJ et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-184.
18. SMITH AD, JOHNSON C, SIM E et al. Protective effect of apo epsilon 2 in Alzheimer's disease. Lancet 1994;344:473-474.
19. TALBOT C, LENDON C, CRADDOCK N, SHEARS S, MORRIS JC, GOATE A. Protection against Alzheimer's disease with apoE epsilon2. Lancet 1994;343:1432-1433.
20. FARRER LA, CUPPLES LA, HAINES JL et al. Effect of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349-1356.
21. MAK YT, CHIU H, WOO J et al. Alpolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 1996;46:146-149.
22. HONG CJ, LIU TY, LIU HC et al. Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology 1996;46:1749-1751.
23. HU CJ, SUNG SM, LIU HC, CHANG JG. Association of apolipoprotein E genotype and intronic polymorphism of the presenilin-1 gene with Alzheimer's disease in elderly Taiwan Chinese. J Neurol Sci 1998;157:158-161.
24. LIU HC, HONG CJ, WANG SJ et al. Apo E genotype in relation to AD and cholesterol: a study of 2,236 Chinese adults. Neurology 1999;53:962-966.
25. YEN YC, LIU CK, LUNG FW, CHONG MY. Apolipoprotein E polymorphism and Alzheimer's disease. Kaohsiung J Med Sci 2001;17:190-197.
26. MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34: 939-944.
27. HIXON JE, VERNIER DT. Restriction isotyping of human APOE by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
28. WENHAM PR, PRICE PH, BLUNDELL A. Apolipoprotein E genotyping by one gate PCR. Lancet 1991;337:1158-1159.
29. KARLSSON JL. Family transmission of schizophrenia: a review and synthesis. Br J Psychiatry 1982;140:600-606.
30. KARLSSON JL. Partly dominant transmission of schizophrenia in Iceland. Br J Psychiatry 1988;152:324-329.
31. ST. GEORGE-HYSLOP PH, HAINES JL, FARRER LA et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogenous disorder. Nature 1990;347:194-197.
32. GOATE A, CHARTIER-HARLIN MC, MULLAN M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349: 704-706.
33. SHERRINGTON R, ROGAEV EL, LIANG Y et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.
34. LEVY-LAHAD E, WASCO W, POORKAJ P et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977.
35. BLACKER D, WILCOX MA, LAIRD NM et al. The genetics of Alzheimer disease: current status and future prospects. Arch Neurol 1998;55:294-296.
36. TSUANG MT, FARAONE SV. The genetics of mood disorders. Baltimore: The Johns Hopkins University Press, 1990.
37. NOGUCHI S, MURAKAMI K, YAMADA N. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:737.
38. UEKI A, KAWANO M, NAMBA Y, KAWAKAMI M, IKEDA K. A high frequency of apolipoprotein epsilon4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993;163:166-168.
39. NAKAYAMA S, KUZUHARA S. Apolipoproeein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Perfecture of Japan. Psychiatry Clin Neurosci 1999;53:643-648.
40. YAMAMOTO Y, YASUDA M, MORI E, MAEDA K. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon 4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999;67:94-96.
41. KIM KW, JHOO JH, LEE KU et al. Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans. Neurosci Lett 1999;277:145-148.
42. ADROER R, SANTACRUZ P, BLESA R, LOPEZ-POUSA S, ASCASO C, OLIVA R. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases. Neurosci Lett 1995;189:182-186.
43. YANG JG, POROPAT RA, BROOKS WS, BROE GA, NICHOLSON GA. Apolipoprotein E genotyping in Alzheimer's disease in an Australian sample. Aust N Z J Med 1996;26:658-661.
44. OUIROGA P, CALVO C, ALBALA C et al. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease. Neuroepidemology 1999;18:48-52.
45. WEINER MF, VEGA G, RISSER RC et al. Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry 1999;45:633-638.
46. MAESTRE G, OTTMAN R, STERN Y et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-259.
47. JORM AF, KORTEN AE, HENDERSON AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-479.
48. BRETSKY PM, BUCKWALTER JG, SEEMAN TE et al. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 1999; 13:216-221.
49. LIN RT, LAI CL, TAI CT, LIU CK, YEN YY, HOWNG SL. Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci 1998;160:67-75.
50. LIU CK, LIN RT, CHEN YF, TAI CT, YEN YY, HOWNG SL. Prevalence of dementia in an urban area in Taiwan. J Formos Med Assoc 1996;95:762-768.
51. LIU HC, FUH JL, WANG SJ et al. Prevalence and subtypes of dementia in a rural Chinese population. Alzheimer Dis Assoc Disord 1998;12:127-134.
52. ZHANG M, KATZMAN R, SALMON D. The prevalence of dementia and Alzheimer's disease in Shanghai. Ann Neurol 1990;27:428-437.